Nasdaq Edges Higher; AngioDynamics Shares Plummet
U.S. stocks pared losses midway through trading, with the Nasdaq Composite turning higher on Thursday.
Why Revelation Biosciences Stock Is Popping Off
Revelation Biosciences Inc (NASDAQ: REVB) shares are trading higher after the company announced an exclusive worldwide license agreement with Vanderbilt University to develop and commercialize phosphorylated hexaacyl disaccharide, for treating or preventing infections.
Revelation Biosciences Q2 EPS $(0.12)
Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(0.12) per share.
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Gainers
Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022.